+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

A mathematical model of the contribution of endothelial progenitor cells to angiogenesis in tumors: implications for antiangiogenic therapy

A mathematical model of the contribution of endothelial progenitor cells to angiogenesis in tumors: implications for antiangiogenic therapy

Blood 102(7): 2555-2561

The traditional view of angiogenesis emphasizes proliferation and migration of vessel wall-associated endothelial cells. However, circulating endothelial progenitor cells have recently been shown to contribute to tumor angiogenesis. Here we quantify the relative contributions of endothelial and endothelial progenitor cells to angiogenesis using a mathematical model. The model predicts that during the early stages of tumor growth, endothelial progenitors have a significant impact on tumor growth and angiogenesis, mediated primarily by their localization in the tumor, not by their proliferation. The model also shows that, as the tumor grows, endothelial progenitors adhere preferentially near the tumor periphery, coincident with the location of highest vascular density, supporting their potential utility as vectors for targeted delivery of therapeutics. Model simulations of various antiangiogenic strategies show that those therapies that effectively target both endothelial and endothelial progenitor cells, either by restoring the balance between angiogenic stimulators and inhibitors or by targeting both types of cells directly, are most effective at delaying tumor growth. The combination of continuous low-dose chemotherapy and antiangiogenic therapy is predicted to have the most significant effect on therapeutic outcome. The model offers new insight into tumor angiogenesis with implications for the rational design of antiangiogenic therapy.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 010067514

Download citation: RISBibTeXText

PMID: 12775571

DOI: 10.1182/blood-2003-02-0365

Related references

Quantitative contribution of endothelial progenitor cells to angiogenesis in solid tumors Predictions of a mathematical model. Proceedings of the American Association for Cancer Research Annual Meeting 43: 896, 2002

Differential CD146 expression on circulating versus tissue endothelial cells in rectal cancer patients: implications for circulating endothelial and progenitor cells as biomarkers for antiangiogenic therapy. Journal of Clinical Oncology 24(9): 1449-1453, 2006

Targeting CD9 produces stimulus-independent antiangiogenic effects predominantly in activated endothelial cells during angiogenesis: a novel antiangiogenic therapy. Biochemical and Biophysical Research Communications 413(1): 128-135, 2011

Nicotine augments the contribution of endothelial progenitor cells to ischemia-induced angiogenesis. Circulation 102(18 Suppl.): II 310, 2000

Exercise training restores the endothelial progenitor cells number and function in hypertension: implications for angiogenesis. Journal of Hypertension 30(11): 2133-2143, 2012

G-CSF stimulates angiogenesis and promotes tumor growth: Potential contribution of bone marrow-derived endothelial progenitor cells. Biochemical & Biophysical Research Communications 297(4): 1058-1061, 2002

Resistin Promotes Angiogenesis in Endothelial Progenitor Cells Through Inhibition of MicroRNA206: Potential Implications for Rheumatoid Arthritis. Stem Cells 33(7): 2243-2255, 2015

Inflammation, angiogenesis, and endothelial progenitor cells: how do endothelial progenitor cells find their place?. Journal of Molecular and Cellular Cardiology 36(4): 459-463, 2004

Bone marrow-derived endothelial progenitor cells do not significantly contribute to angiogenesis in a tumor model. Journal of the American College of Cardiology 35(2 Suppl A): 278A, 2000

Shock wave treatment induces angiogenesis and mobilizes endogenous CD31/CD34-positive endothelial cells in a hindlimb ischemia model: implications for angiogenesis and vasculogenesis. Journal of Thoracic and Cardiovascular Surgery 146(4): 971-978, 2013

Overview of angiogenesis: Biologic implications for antiangiogenic therapy. Seminars in Oncology 28(5 Suppl 16): 94, 2001

Heterogeneity of angiogenesis and blood vessel maturation in human tumors: implications for antiangiogenic tumor therapies. Cancer Research 60(5): 1388-1393, 2000

Tumor angiogenesis promoted by ex vivo differentiated endothelial progenitor cells is effectively inhibited by an angiogenesis inhibitor, TK1-2. Cancer Research 67(10): 4851-4859, 2007

Melittin inhibits tumor angiogenesis modulated by endothelial progenitor cells associated with the SDF-1α/CXCR4 signaling pathway in a UMR-106 osteosarcoma xenograft mouse model. Molecular Medicine Reports 14(1): 57-68, 2016